EMVC.
32 announcements.
32 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 30-09-2025 | EMVC | Emv Capital | Interim Results and Investor Presentation |
| 07:00 | 22-09-2025 | EMVC | Emv Capital | Asset Purchase Agreement with Destiny Pharma |
| 07:00 | 18-09-2025 | EMVC | Emv Capital | Notice of Interim Results |
| 12:22 | 30-06-2025 | EMVC | Emv Capital | Result of AGM |
| 07:00 | 30-06-2025 | EMVC | Emv Capital | Office move and Related Party Transaction |
| 07:00 | 27-06-2025 | EMVC | Emv Capital | Q-Bot Limited Fundraising |
| 13:28 | 10-06-2025 | EMVC | Emv Capital | TR-1 |
| 15:12 | 06-06-2025 | EMVC | Emv Capital | Notice of AGM and Annual Report & Accounts |
| 14:34 | 04-06-2025 | EMVC | Emv Capital | Director/PDMR Shareholding |
| 07:00 | 04-06-2025 | EMVC | Emv Capital | Preliminary results for the year ended 31 Dec 2024 |
| 16:02 | 14-05-2025 | EMVC | Emv Capital | PDS: Q1 Results and Clinical and Corporate Update |
| 10:30 | 09-05-2025 | EMVC | Emv Capital | TR-1 |
| 16:46 | 27-03-2025 | EMVC | Emv Capital | PDS: Q4 Results and Clinical Programs Update |
| 16:26 | 07-03-2025 | EMVC | Emv Capital | PDS: VERSATILE-003 Phase 3 Clinical Trial |
| 16:30 | 27-02-2025 | EMVC | Emv Capital | PDS: up to $22mn Registered Direct Offering |
| 15:24 | 05-02-2025 | EMVC | Emv Capital | PDS Biotech reaffirms guidance for clinical trial |
| 07:00 | 03-02-2025 | EMVC | Emv Capital | ProAxsis: Status Update and Proposed Fundraise |
| 16:42 | 06-01-2025 | EMVC | Emv Capital | TR-1 |
| 07:05 | 31-12-2024 | EMVC | Emv Capital | Grant of Share Options |
| 07:00 | 31-12-2024 | EMVC | Emv Capital | Q-Bot Fundraising |
| 16:49 | 12-12-2024 | EMVC | Emv Capital | TR-1 |
| 07:00 | 09-12-2024 | EMVC | Emv Capital | Wanda Health Fundraising |
| 07:00 | 05-12-2024 | EMVC | Emv Capital | Close of Fundraising and Result of Retail Offer |
| 13:24 | 03-12-2024 | EMVC | Emv Capital | Result of Subscription |
| 07:05 | 03-12-2024 | EMVC | Emv Capital | WRAP Retail Offer |
| 07:00 | 03-12-2024 | EMVC | Emv Capital | Proposed Subscription and Retail Offer; Update |
| 15:59 | 14-11-2024 | EMVC | EMVC | Replacement RNS: PDS: Update, 3rd Quarter Results |
| 15:23 | 14-11-2024 | EMVC | EMVC | PDS: Clinical Programs Update, 3rd Quarter Results |
| 07:00 | 08-10-2024 | EMVC | EMVC | Director/PDMR Shareholding |
| 07:00 | 03-10-2024 | EMVC | EMVC | Director/PDMR Shareholding |
| 07:00 | 30-09-2024 | EMVC | EMVC | Interim Results |
| 07:00 | 26-09-2024 | EMVC | EMVC | Name change and AIM Rule 26 website |